Kathryn Shade, MD
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shade’s office at (408) 378-1101 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A98540 · Current
Licensed to practise in California · since 2007 · expires 2029-01-31 · University of California, San Diego School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$61,490
Medicare paid this office $61,490 for 116 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 67 | $15,049 | $115 |
| Short return visit (20+ min) | 74 | $12,427 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 77 | $12,118 | $157 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,788 | $291 |
| Influenza vaccine split virus, preservative free | 39 | $3,191 | $82 |
See all 13 services
| Return visit (30+ min) | 67 | $15,049 | $115 |
| Short return visit (20+ min) | 74 | $12,427 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 77 | $12,118 | $157 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,788 | $291 |
| Influenza vaccine split virus, preservative free | 39 | $3,191 | $82 |
| Sarscv2 vac 30mcg trs-suc im | 21 | $3,014 | $144 |
| Annual depression screening, 5 to 15 minutes | 74 | $1,801 | $24 |
| Administration of influenza virus vaccine | 38 | $1,485 | $39 |
| Admn sarscov2 vacc 1 dose | 21 | $1,094 | $52 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 28 | $684 | $15 |
| Short return visit | 13 | $671 | $52 |
| Administration of pneumococcal vaccine | 14 | $547 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $154 | $13 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
116 Original Medicare patients in 2024. Average age 74 · Women 83% · Health risk score 0.87. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 55% · Coronary heart disease 22% · Depression 21% · Cancer 16% · Diabetes 15% · Chronic kidney disease 12% · Atrial fibrillation 11% · Stroke 10% · COPD 9%.
The office billed $143,696, Medicare allowed $73,348 and paid $61,490; for 762 services of 34 kinds; $10,174 of it was for drugs given in the office and $51,315 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 116 | 762 | 74 | 0.87 | $143,696 | $61,490 |
| 2023 | 103 | 550 | 74 | 0.90 | $113,397 | $42,292 |
| 2022 | 138 | 826 | 73 | 0.83 | $125,514 | $58,896 |
| 2021 | 203 | 906 | 74 | 0.81 | $130,649 | $66,923 |
| 2020 | 176 | 796 | 73 | 0.82 | $164,907 | $54,946 |
| 2019 | 154 | 795 | 73 | 0.80 | $155,585 | $52,418 |
| 2018 | 147 | 765 | 72 | 0.84 | $145,399 | $48,477 |
| 2017 | 157 | 1,033 | 71 | 0.82 | $156,708 | $52,873 |
| 2016 | 147 | 795 | 70 | 0.76 | $111,391 | $48,503 |
| 2015 | 121 | 728 | 69 | 0.63 | $64,609 | $39,673 |
| 2014 | 112 | 625 | 69 | 0.61 | $55,522 | $34,568 |
| 2013 | 92 | 311 | 69 | 0.67 | $30,323 | $18,804 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 70 | $10,745 | $67 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $8,575 | $156 |
| Return visit (30+ min) | 56 | $8,097 | $95 |
| Sarscv2 vac 30mcg trs-suc im | 12 | $1,542 | $128 |
| Influenza vaccine split virus, preservative free | 20 | $1,439 | $72 |
| Annual depression screening, 5 to 15 minutes | 45 | $1,020 | $23 |
| Administration of influenza virus vaccine | 25 | $924 | $37 |
| Admn sarscov2 vacc 1 dose | 12 | $591 | $49 |
| Short return visit | 14 | $577 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $184 | $13 |
2022: 11 services
| Short return visit (20+ min) | 103 | $18,082 | $67 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $12,631 | $152 |
| Return visit (30+ min) | 61 | $9,878 | $94 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 16 | $4,401 | $275 |
| Influenza vaccine split virus, preservative free | 44 | $3,016 | $69 |
| Annual depression screening, 5 to 15 minutes | 82 | $1,872 | $23 |
| Administration of influenza virus vaccine | 49 | $1,824 | $37 |
| Short return visit | 22 | $964 | $39 |
| Administration of pneumococcal vaccine | 22 | $826 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $309 | $13 |
| Stool analysis for blood to screen for colon tumors | 22 | $95 | $4 |
2021: 9 services
| Short return visit (20+ min) | 133 | $22,416 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 93 | $13,969 | $150 |
| Return visit (30+ min) | 82 | $11,595 | $95 |
| Influenza vaccine split virus, preservative free | 80 | $5,221 | $65 |
| Short return visit | 38 | $2,183 | $39 |
| Administration of influenza virus vaccine | 85 | $1,837 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 38 | $529 | $13 |
| Administration of pneumococcal vaccine | 14 | $303 | $22 |
| Stool analysis for blood to screen for colon tumors | 21 | $92 | $4 |
2020: 12 services
| Short return visit (20+ min) | 128 | $18,908 | $65 |
| Return visit (30+ min) | 75 | $11,132 | $91 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $7,776 | $139 |
| Influenza vaccine split virus, preservative free | 49 | $2,982 | $61 |
| Short return visit | 35 | $2,249 | $43 |
| Pneumococcal vaccine, 23-valent | 12 | $1,399 | $117 |
| Administration of influenza virus vaccine | 57 | $1,213 | $21 |
| Administration of pneumococcal vaccine | 16 | $395 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $203 | $16 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 11 | $122 | $11 |
| Stool analysis for blood to screen for colon tumors | 15 | $65 | $4 |
| Urinalysis, manual test | 11 | $45 | $3 |
2019: 11 services
| Short return visit (20+ min) | 104 | $14,253 | $64 |
| Return visit (30+ min) | 73 | $10,992 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 78 | $10,858 | $139 |
| Influenza vaccine split virus, preservative free | 45 | $2,619 | $53 |
| Pneumococcal vaccine, 23-valent | 22 | $2,536 | $110 |
| Short return visit | 30 | $1,141 | $37 |
| Administration of influenza virus vaccine | 48 | $1,087 | $21 |
| Administration of pneumococcal vaccine | 27 | $574 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 34 | $513 | $14 |
| Stool analysis for blood to screen for colon tumors | 30 | $129 | $4 |
| Urinalysis, manual test | 12 | $41 | $3 |
2018: 11 services
| Return visit (30+ min) | 78 | $12,455 | $88 |
| Short return visit (20+ min) | 83 | $11,071 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 71 | $9,966 | $140 |
| Influenza vaccine split virus, preservative free | 53 | $2,772 | $52 |
| Administration of influenza virus vaccine | 57 | $1,467 | $26 |
| Pneumococcal vaccine, 23-valent | 11 | $1,161 | $106 |
| Short return visit | 19 | $810 | $40 |
| Administration of pneumococcal vaccine | 16 | $437 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $264 | $13 |
| Blood test, lipids (cholesterol and triglycerides) | 13 | $243 | $16 |
| Stool analysis for blood to screen for colon tumors | 14 | $60 | $4 |
2017: 13 services
| Return visit (30+ min) | 82 | $11,181 | $82 |
| Short return visit (20+ min) | 103 | $10,825 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 74 | $10,251 | $139 |
| Pneumococcal vaccine, 13-valent | 23 | $4,029 | $175 |
| Influenza vaccine split virus, preservative free | 68 | $3,297 | $46 |
| Administration of influenza virus vaccine | 73 | $2,422 | $31 |
| Administration of pneumococcal vaccine | 20 | $646 | $32 |
| Short return visit | 14 | $586 | $37 |
| Annual depression screening, 5 to 15 minutes | 17 | $356 | $21 |
| Blood test, lipids (cholesterol and triglycerides) | 15 | $270 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $247 | $14 |
| Stool analysis for blood to screen for colon tumors | 20 | $83 | $4 |
| Urinalysis, manual test | 11 | $38 | $3 |
2016: 15 services
| Short return visit (20+ min) | 90 | $11,402 | $62 |
| Return visit (30+ min) | 77 | $10,511 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,057 | $138 |
| Pneumococcal vaccine, 13-valent | 27 | $4,737 | $175 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $3,012 | $201 |
| Influenza vaccine split virus, preservative free | 56 | $2,175 | $38 |
| Administration of influenza virus vaccine | 60 | $1,932 | $31 |
| Short return visit | 20 | $1,028 | $40 |
| Administration of pneumococcal vaccine | 27 | $855 | $32 |
| Annual depression screening, 5 to 15 minutes | 31 | $686 | $22 |
| Blood test, lipids (cholesterol and triglycerides) | 23 | $519 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $361 | $14 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 12 | $176 | $15 |
| Insertion of needle into vein for collection of blood sample | 23 | $88 | $3 |
| Urinalysis, manual test | 12 | $51 | $3 |
2015: 14 services
| Short return visit (20+ min) | 85 | $10,670 | $56 |
| Return visit (30+ min) | 58 | $8,264 | $86 |
| Pneumococcal vaccine, 13-valent | 29 | $4,733 | $163 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 17 | $3,405 | $200 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,462 | $137 |
| Administration of influenza virus vaccine | 40 | $1,240 | $31 |
| Administration of pneumococcal vaccine | 28 | $888 | $32 |
| Short return visit | 17 | $654 | $34 |
| Influenza vaccine split virus, preservative free | 17 | $605 | $36 |
| Blood test, lipids (cholesterol and triglycerides) | 23 | $500 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $487 | $15 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 20 | $295 | $15 |
| Insertion of needle into vein for collection of blood sample | 18 | $68 | $3 |
| Urinalysis, manual test | 16 | $55 | $3 |
2014: 12 services
| Short return visit (20+ min) | 81 | $10,513 | $60 |
| Return visit (30+ min) | 51 | $6,985 | $85 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 19 | $3,768 | $198 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 15 | $2,869 | $191 |
| Pneumococcal vaccine, 13-valent | 15 | $2,255 | $150 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,752 | $135 |
| Administration of influenza virus vaccine | 44 | $1,432 | $31 |
| Short return visit | 21 | $812 | $34 |
| Administration of pneumococcal vaccine | 14 | $436 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 34 | $396 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $272 | $16 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 12 | $101 | $8 |
2013: 6 services
| Short return visit (20+ min) | 74 | $7,652 | $58 |
| Return visit (30+ min) | 24 | $2,220 | $72 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $2,194 | $199 |
| Administration of influenza virus vaccine | 27 | $868 | $32 |
| Short return visit | 12 | $377 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 27 | $233 | $9 |
Drugs they prescribed that Part D paid
$115,758
Pharmacies billed $115,758 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (45 of 1,428) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,274 generic and fewer than 11 brand-name prescriptions · $115,758 in drug cost · 62 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 22 | $20,963 | $953 |
| Duloxetine | 36 | $2,979 | $83 |
| Estradiol (Twice Weekly) | 21 | $1,591 | $76 |
| Gabapentin | 45 | $1,037 | $23 |
| Levothyroxine | 78 | $966 | $12 |
See all 41 drugs
| Ozempic | 22 | $20,963 | $953 |
| Duloxetine | 36 | $2,979 | $83 |
| Estradiol (Twice Weekly) | 21 | $1,591 | $76 |
| Gabapentin | 45 | $1,037 | $23 |
| Levothyroxine | 78 | $966 | $12 |
| Atorvastatin | 105 | $960 | $9 |
| Escitalopram | 45 | $942 | $21 |
| Rosuvastatin | 40 | $927 | $23 |
| Oxybutynin Chloride Er | 18 | $584 | $32 |
| Losartan-Hydrochlorothiazide | 26 | $566 | $22 |
| Estradiol | 22 | $465 | $21 |
| Metoprolol | 30 | $445 | $15 |
| Losartan | 33 | $344 | $10 |
| Donepezil | 14 | $322 | $23 |
| Celecoxib | 12 | $313 | $26 |
| Hydrocodone-Acetaminophen | 15 | $296 | $20 |
| Fluoxetine | 11 | $275 | $25 |
| Tamsulosin | 12 | $273 | $23 |
| Lisinopril | 36 | $258 | $7 |
| Tramadol | 18 | $220 | $12 |
| Pantoprazole | 24 | $216 | $9 |
| Hydrochlorothiazide | 20 | $190 | $10 |
| Progesterone | 12 | $180 | $15 |
| Venlafaxine Hcl Er | 12 | $177 | $15 |
| Atenolol | 12 | $173 | $14 |
| Zolpidem | 25 | $170 | $7 |
| Famotidine | 15 | $150 | $10 |
| Clonazepam | 24 | $141 | $6 |
| Allopurinol | 17 | $138 | $8 |
| Acyclovir | 11 | $126 | $11 |
| Lorazepam | 16 | $97 | $6 |
| Pravastatin | 12 | $77 | $6 |
| Doxycycline Hyclate | 11 | $73 | $7 |
| Sertraline | 14 | $63 | $4 |
| Amoxicillin-Clavulanate Potass | 11 | $58 | $5 |
| Alprazolam | 18 | $57 | $3 |
| Alendronate | 18 | $53 | $3 |
| Metformin | 13 | $33 | $3 |
| Diazepam | 12 | $24 | $2 |
| Amlodipine Besylate | 12 | $21 | $2 |
| Meloxicam | 14 | $9 | $1 |
Year by year
| 2024 | 1,428 | 123 | 3% (45) | None | $115,758 |
| 2023 | 1,290 | 113 | 3% (32) | 11% | $124,483 |
| 2022 | 1,440 | 175 | 3% (36) | 11% | $129,339 |
| 2021 | 1,955 | 202 | 1% (25) | None | $158,782 |
| 2020 | 1,935 | 177 | 3% (54) | None | $169,483 |
| 2019 | 1,520 | 138 | 2% (35) | None | $127,129 |
| 2018 | 1,352 | 126 | 2% (27) | None | $92,393 |
| 2017 | 1,336 | 122 | 2% (22) | None | $82,822 |
| 2016 | 1,274 | 98 | 2% (28) | 19% | $75,343 |
| 2015 | 1,072 | 96 | 2% (17) | 19% | $60,231 |
| 2014 | 938 | 86 | 2% (20) | 17% | $49,046 |
| 2013 | 576 | 62 | 3% (16) | None | $31,716 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Rybelsus | 16 | $25,975 | $1,623 |
| Duloxetine | 29 | $1,741 | $60 |
| Dexlansoprazole Dr | 11 | $1,461 | $133 |
| Levothyroxine | 84 | $1,349 | $16 |
| Atorvastatin | 113 | $1,264 | $11 |
| Gabapentin | 39 | $1,200 | $31 |
| Rosuvastatin | 34 | $1,146 | $34 |
| Estradiol | 27 | $804 | $30 |
| Escitalopram | 40 | $798 | $20 |
| Metoprolol | 32 | $637 | $20 |
| Losartan-Hydrochlorothiazide | 30 | $499 | $17 |
| Ibandronate | 12 | $448 | $37 |
| Lisinopril | 40 | $362 | $9 |
| Losartan | 28 | $342 | $12 |
| Venlafaxine Hcl Er | 11 | $285 | $26 |
| Allopurinol | 20 | $262 | $13 |
| Pravastatin | 12 | $198 | $16 |
| Sertraline | 12 | $192 | $16 |
| Hydrocodone-Acetaminophen | 21 | $182 | $9 |
| Zolpidem | 19 | $170 | $9 |
| Omeprazole | 19 | $157 | $8 |
| Hydrochlorothiazide | 19 | $140 | $7 |
| Pantoprazole | 11 | $132 | $12 |
| Clonazepam | 35 | $125 | $4 |
| Paxlovid (Eua) | 11 | $113 | $10 |
| Atenolol | 12 | $111 | $9 |
| Simvastatin | 12 | $98 | $8 |
| Alendronate | 18 | $83 | $5 |
2022: 32 drugs
| Bydureon Bcise | 16 | $12,829 | $802 |
| Dantrolene | 11 | $1,996 | $181 |
| Atorvastatin | 139 | $1,718 | $12 |
| Levothyroxine | 97 | $1,526 | $16 |
| Rosuvastatin | 36 | $1,267 | $35 |
| Duloxetine | 27 | $1,251 | $46 |
| Escitalopram | 53 | $1,187 | $22 |
| Estradiol | 21 | $1,040 | $50 |
| Gabapentin | 41 | $690 | $17 |
| Losartan-Hydrochlorothiazide | 27 | $685 | $25 |
| Metoprolol | 32 | $654 | $20 |
| Metformin | 26 | $528 | $20 |
| Amlodipine Besylate | 16 | $440 | $28 |
| Omeprazole | 31 | $436 | $14 |
| Hydrocodone-Acetaminophen | 23 | $353 | $15 |
| Benazepril | 11 | $345 | $31 |
| Trazodone | 15 | $331 | $22 |
| Losartan | 28 | $264 | $9 |
| Topiramate | 11 | $245 | $22 |
| Temazepam | 12 | $208 | $17 |
| Fluoxetine | 17 | $200 | $12 |
| Allopurinol | 16 | $199 | $12 |
| Lisinopril | 41 | $189 | $5 |
| Clonazepam | 49 | $188 | $4 |
| Atenolol | 17 | $178 | $10 |
| Pravastatin | 11 | $177 | $16 |
| Alendronate | 13 | $168 | $13 |
| Hydrochlorothiazide | 35 | $162 | $5 |
| Simvastatin | 22 | $132 | $6 |
| Sertraline | 12 | $132 | $11 |
| Zolpidem | 13 | $92 | $7 |
| Lorazepam | 12 | $35 | $3 |
2021: 50 drugs
| Jardiance | 20 | $16,968 | $848 |
| Bydureon Bcise | 13 | $10,494 | $807 |
| Advair Diskus | 13 | $6,294 | $484 |
| Dexilant | 12 | $3,617 | $301 |
| Atorvastatin | 162 | $2,682 | $17 |
| Levothyroxine | 123 | $2,540 | $21 |
| Olmesartan-Hydrochlorothiazide | 21 | $2,190 | $104 |
| Dantrolene | 12 | $2,075 | $173 |
| Synthroid | 27 | $1,644 | $61 |
| Metoprolol | 40 | $1,294 | $32 |
| Losartan-Hydrochlorothiazide | 24 | $1,072 | $45 |
| Gabapentin | 55 | $913 | $17 |
| Losartan | 43 | $834 | $19 |
| Escitalopram | 55 | $828 | $15 |
| Rosuvastatin | 34 | $747 | $22 |
| Omeprazole | 29 | $640 | $22 |
| Atenolol | 23 | $638 | $28 |
| Valacyclovir | 11 | $581 | $53 |
| Pantoprazole | 22 | $546 | $25 |
| Duloxetine | 20 | $545 | $27 |
| Doxepin | 13 | $545 | $42 |
| Sertraline | 41 | $543 | $13 |
| Venlafaxine Hcl Er | 18 | $506 | $28 |
| Pravastatin | 24 | $492 | $21 |
| Estradiol | 18 | $486 | $27 |
| Ibandronate | 14 | $478 | $34 |
| Fluoxetine | 17 | $447 | $26 |
| Paroxetine | 18 | $446 | $25 |
| Lisinopril | 59 | $413 | $7 |
| Simvastatin | 47 | $405 | $9 |
| Tamsulosin | 12 | $350 | $29 |
| Clonazepam | 35 | $340 | $10 |
| Metformin | 39 | $338 | $9 |
| Temazepam | 18 | $318 | $18 |
| Triamcinolone Acetonide | 13 | $310 | $24 |
| Hydrochlorothiazide | 68 | $300 | $4 |
| Hydrocodone-Acetaminophen | 15 | $282 | $19 |
| Hydroxyzine | 12 | $280 | $23 |
| Montelukast | 14 | $277 | $20 |
| Allopurinol | 20 | $269 | $13 |
| Topiramate | 11 | $259 | $24 |
| Trazodone | 21 | $227 | $11 |
| Benazepril | 11 | $212 | $19 |
| Amlodipine Besylate | 27 | $165 | $6 |
| Alprazolam | 27 | $139 | $5 |
| Lisinopril-Hydrochlorothiazide | 15 | $99 | $7 |
| Lorazepam | 29 | $86 | $3 |
| Ciprofloxacin | 17 | $76 | $4 |
| Carisoprodol | 13 | $52 | $4 |
| Diazepam | 14 | $40 | $3 |
2020: 44 drugs
| Jardiance | 24 | $14,061 | $586 |
| Bydureon Bcise | 11 | $8,589 | $781 |
| Vascepa | 19 | $7,947 | $418 |
| Advair Diskus | 14 | $7,102 | $507 |
| Dexilant | 13 | $3,739 | $288 |
| Levothyroxine | 132 | $3,545 | $27 |
| Atorvastatin | 139 | $2,348 | $17 |
| Dantrolene | 12 | $2,194 | $183 |
| Losartan-Hydrochlorothiazide | 22 | $1,556 | $71 |
| Synthroid | 24 | $1,554 | $65 |
| Valacyclovir | 25 | $1,437 | $57 |
| Bupropion Xl | 14 | $1,260 | $90 |
| Metoprolol | 35 | $1,112 | $32 |
| Rosuvastatin | 37 | $915 | $25 |
| Olmesartan-Hydrochlorothiazide | 15 | $864 | $58 |
| Omeprazole | 41 | $844 | $21 |
| Amitriptyline | 19 | $823 | $43 |
| Gabapentin | 42 | $756 | $18 |
| Pravastatin | 30 | $743 | $25 |
| Losartan | 54 | $732 | $14 |
| Hydrocodone-Acetaminophen | 31 | $724 | $23 |
| Estradiol | 15 | $646 | $43 |
| Lisinopril | 63 | $624 | $10 |
| Clonazepam | 40 | $571 | $14 |
| Escitalopram | 34 | $540 | $16 |
| Simvastatin | 60 | $513 | $9 |
| Sertraline | 33 | $508 | $15 |
| Allopurinol | 19 | $403 | $21 |
| Hydrochlorothiazide | 62 | $382 | $6 |
| Atenolol | 27 | $373 | $14 |
| Topiramate | 16 | $333 | $21 |
| Montelukast | 13 | $330 | $25 |
| Diclofenac | 14 | $326 | $23 |
| Metformin | 32 | $294 | $9 |
| Duloxetine | 12 | $254 | $21 |
| Paroxetine | 14 | $237 | $17 |
| Amlodipine Besylate | 28 | $145 | $5 |
| Alprazolam | 24 | $144 | $6 |
| Metformin Hcl Er | 13 | $141 | $11 |
| Cyclobenzaprine | 11 | $141 | $13 |
| Lorazepam | 30 | $138 | $5 |
| Lisinopril-Hydrochlorothiazide | 11 | $127 | $12 |
| Diazepam | 29 | $110 | $4 |
| Prednisone | 14 | $42 | $3 |
2019: 43 drugs
| Invokana | 11 | $8,844 | $804 |
| Eliquis | 15 | $8,820 | $588 |
| Vascepa | 16 | $7,125 | $445 |
| Dexilant | 13 | $3,706 | $285 |
| Levothyroxine | 96 | $2,304 | $24 |
| Hydrocodone-Acetaminophen | 19 | $2,168 | $114 |
| Atorvastatin | 117 | $2,132 | $18 |
| Synthroid | 16 | $1,482 | $93 |
| Amitriptyline | 24 | $1,308 | $55 |
| Bupropion Xl | 15 | $909 | $61 |
| Metoprolol | 17 | $861 | $51 |
| Valacyclovir | 15 | $794 | $53 |
| Olmesartan-Hydrochlorothiazide | 12 | $739 | $62 |
| Escitalopram | 20 | $738 | $37 |
| Losartan | 53 | $722 | $14 |
| Gabapentin | 29 | $644 | $22 |
| Ketoconazole | 13 | $636 | $49 |
| Simvastatin | 51 | $618 | $12 |
| Rosuvastatin | 25 | $594 | $24 |
| Estradiol | 17 | $590 | $35 |
| Omeprazole | 22 | $540 | $25 |
| Temazepam | 15 | $494 | $33 |
| Losartan-Hydrochlorothiazide | 21 | $483 | $23 |
| Paroxetine | 21 | $452 | $22 |
| Pravastatin | 19 | $430 | $23 |
| Lisinopril | 38 | $411 | $11 |
| Atenolol | 22 | $399 | $18 |
| Clonazepam | 28 | $364 | $13 |
| Montelukast | 13 | $359 | $28 |
| Morphine Sulfate Er | 11 | $347 | $32 |
| Allopurinol | 15 | $334 | $22 |
| Hydrochlorothiazide | 42 | $308 | $7 |
| Topiramate | 14 | $279 | $20 |
| Sertraline | 29 | $273 | $9 |
| Alprazolam | 31 | $261 | $8 |
| Citalopram Hbr | 17 | $254 | $15 |
| Metformin | 26 | $213 | $8 |
| Lisinopril-Hydrochlorothiazide | 18 | $168 | $9 |
| Amlodipine Besylate | 12 | $133 | $11 |
| Diazepam | 18 | $85 | $5 |
| Lorazepam | 18 | $84 | $5 |
| Azithromycin | 13 | $78 | $6 |
| Triamcinolone Acetonide | 11 | $45 | $4 |
2018: 40 drugs
| Invokana | 11 | $8,169 | $743 |
| Vascepa | 14 | $5,554 | $397 |
| Synthroid | 18 | $1,898 | $105 |
| Levothyroxine | 57 | $1,808 | $32 |
| Atorvastatin | 103 | $1,747 | $17 |
| Bupropion Xl | 21 | $1,207 | $57 |
| Amitriptyline | 31 | $934 | $30 |
| Gabapentin | 38 | $896 | $24 |
| Bupropion Hcl Sr | 13 | $830 | $64 |
| Valacyclovir | 12 | $694 | $58 |
| Losartan | 51 | $585 | $11 |
| Metoprolol | 14 | $558 | $40 |
| Rosuvastatin | 19 | $538 | $28 |
| Simvastatin | 53 | $536 | $10 |
| Omeprazole | 15 | $450 | $30 |
| Olmesartan-Hydrochlorothiazide | 11 | $418 | $38 |
| Allopurinol | 18 | $398 | $22 |
| Morphine Sulfate Er | 12 | $389 | $32 |
| Escitalopram | 26 | $361 | $14 |
| Buspirone | 11 | $348 | $32 |
| Tamsulosin | 14 | $339 | $24 |
| Pravastatin | 12 | $338 | $28 |
| Atenolol | 26 | $333 | $13 |
| Losartan-Hydrochlorothiazide | 15 | $315 | $21 |
| Paroxetine | 29 | $288 | $10 |
| Metformin | 22 | $237 | $11 |
| Hydrochlorothiazide | 33 | $210 | $6 |
| Topiramate | 14 | $185 | $13 |
| Lisinopril | 23 | $174 | $8 |
| Lisinopril-Hydrochlorothiazide | 20 | $157 | $8 |
| Citalopram Hbr | 13 | $151 | $12 |
| Azithromycin | 19 | $135 | $7 |
| Alprazolam | 22 | $127 | $6 |
| Amlodipine Besylate | 17 | $123 | $7 |
| Zolpidem | 11 | $121 | $11 |
| Clonazepam | 17 | $102 | $6 |
| Sertraline | 26 | $88 | $3 |
| Lorazepam | 15 | $83 | $6 |
| Ciprofloxacin | 14 | $67 | $5 |
| Diazepam | 16 | $64 | $4 |
2017: 40 drugs
| Invokana | 15 | $11,407 | $760 |
| Livalo | 24 | $9,201 | $383 |
| Trintellix | 13 | $4,894 | $376 |
| Vascepa | 11 | $2,776 | $252 |
| Atorvastatin | 86 | $1,606 | $19 |
| Synthroid | 22 | $1,550 | $70 |
| Levothyroxine | 61 | $1,542 | $25 |
| Celecoxib | 13 | $1,226 | $94 |
| Bupropion Xl | 19 | $809 | $43 |
| Gabapentin | 48 | $764 | $16 |
| Buspirone | 18 | $647 | $36 |
| Rosuvastatin | 15 | $598 | $40 |
| Valacyclovir | 12 | $491 | $41 |
| Tamsulosin | 16 | $367 | $23 |
| Losartan-Hydrochlorothiazide | 21 | $364 | $17 |
| Simvastatin | 54 | $355 | $7 |
| Montelukast | 13 | $330 | $25 |
| Amitriptyline | 18 | $321 | $18 |
| Losartan | 35 | $315 | $9 |
| Lisinopril | 30 | $310 | $10 |
| Paroxetine | 25 | $309 | $12 |
| Metoprolol | 12 | $294 | $24 |
| Omeprazole | 13 | $282 | $22 |
| Atenolol | 39 | $281 | $7 |
| Escitalopram | 29 | $275 | $9 |
| Allopurinol | 11 | $227 | $21 |
| Zolpidem | 12 | $210 | $18 |
| Metformin | 25 | $207 | $8 |
| Topiramate | 12 | $185 | $15 |
| Amlodipine Besylate | 21 | $159 | $8 |
| Alprazolam | 22 | $146 | $7 |
| Hydrochlorothiazide | 33 | $133 | $4 |
| Valsartan-Hydrochlorothiazide | 11 | $121 | $11 |
| Lisinopril-Hydrochlorothiazide | 11 | $115 | $10 |
| Sertraline | 14 | $91 | $7 |
| Prednisone | 11 | $80 | $7 |
| Ciprofloxacin | 15 | $69 | $5 |
| Diazepam | 24 | $62 | $3 |
| Azithromycin | 12 | $61 | $5 |
| Clonazepam | 17 | $53 | $3 |
2016: 38 drugs
| Livalo | 28 | $6,030 | $215 |
| Uloric | 11 | $3,069 | $279 |
| Vascepa | 11 | $2,557 | $232 |
| Levothyroxine | 75 | $1,773 | $24 |
| Atorvastatin | 75 | $1,739 | $23 |
| Chlorthalidone | 17 | $1,215 | $71 |
| Synthroid | 11 | $1,057 | $96 |
| Bupropion Xl | 22 | $745 | $34 |
| Buspirone | 13 | $642 | $49 |
| Montelukast | 17 | $619 | $36 |
| Metoprolol | 12 | $521 | $43 |
| Simvastatin | 70 | $464 | $7 |
| Tamsulosin | 20 | $453 | $23 |
| Omeprazole | 20 | $420 | $21 |
| Valacyclovir | 16 | $387 | $24 |
| Losartan | 29 | $372 | $13 |
| Amlodipine Besylate | 28 | $347 | $12 |
| Atenolol | 42 | $322 | $8 |
| Gabapentin | 23 | $295 | $13 |
| Tramadol | 14 | $276 | $20 |
| Lovastatin | 14 | $254 | $18 |
| Losartan-Hydrochlorothiazide | 18 | $248 | $14 |
| Metformin | 25 | $247 | $10 |
| Lisinopril | 20 | $237 | $12 |
| Paroxetine | 18 | $214 | $12 |
| Topiramate | 11 | $199 | $18 |
| Metoprolol | 14 | $188 | $13 |
| Pravastatin | 11 | $187 | $17 |
| Hydrochlorothiazide | 31 | $144 | $5 |
| Lorazepam | 12 | $114 | $9 |
| Lisinopril-Hydrochlorothiazide | 13 | $108 | $8 |
| Escitalopram | 12 | $107 | $9 |
| Triamcinolone Acetonide | 12 | $101 | $8 |
| Azithromycin | 14 | $100 | $7 |
| Alprazolam | 15 | $78 | $5 |
| Diazepam | 16 | $76 | $5 |
| Sertraline | 21 | $70 | $3 |
| Clonazepam | 13 | $33 | $3 |
2015: 32 drugs
| Livalo | 21 | $3,465 | $165 |
| Benicar Hct | 11 | $3,171 | $288 |
| Levothyroxine | 63 | $1,779 | $28 |
| Bupropion Xl | 21 | $1,671 | $80 |
| Atorvastatin | 42 | $865 | $21 |
| Chlorthalidone | 12 | $695 | $58 |
| Simvastatin | 83 | $633 | $8 |
| Montelukast | 12 | $568 | $47 |
| Bupropion Hcl Sr | 11 | $535 | $49 |
| Duloxetine | 11 | $533 | $48 |
| Tamsulosin | 17 | $522 | $31 |
| Amitriptyline | 18 | $463 | $26 |
| Pravastatin | 12 | $374 | $31 |
| Metformin | 32 | $313 | $10 |
| Losartan | 23 | $268 | $12 |
| Omeprazole | 17 | $245 | $14 |
| Zolpidem | 11 | $231 | $21 |
| Gabapentin | 22 | $211 | $10 |
| Lisinopril | 19 | $205 | $11 |
| Amlodipine Besylate | 16 | $204 | $13 |
| Atenolol | 33 | $182 | $6 |
| Sertraline | 27 | $168 | $6 |
| Lisinopril-Hydrochlorothiazide | 15 | $141 | $9 |
| Lorazepam | 15 | $136 | $9 |
| Paroxetine | 15 | $129 | $9 |
| Fluoxetine | 11 | $124 | $11 |
| Hydrochlorothiazide | 28 | $113 | $4 |
| Lovastatin | 12 | $74 | $6 |
| Meloxicam | 11 | $73 | $7 |
| Diazepam | 17 | $68 | $4 |
| Ciprofloxacin | 12 | $60 | $5 |
| Alprazolam | 11 | $59 | $5 |
2014: 26 drugs
| Vagifem | 11 | $1,296 | $118 |
| Levothyroxine | 38 | $1,091 | $29 |
| Montelukast | 13 | $1,036 | $80 |
| Bupropion Xl | 17 | $825 | $49 |
| Simvastatin | 90 | $815 | $9 |
| Gabapentin | 38 | $777 | $20 |
| Omeprazole | 31 | $610 | $20 |
| Chlorthalidone | 11 | $548 | $50 |
| Atorvastatin | 18 | $514 | $29 |
| Losartan | 28 | $416 | $15 |
| Fluoxetine | 16 | $399 | $25 |
| Amitriptyline | 21 | $313 | $15 |
| Metformin | 32 | $300 | $9 |
| Buspirone | 15 | $271 | $18 |
| Sertraline | 23 | $223 | $10 |
| Zolpidem | 16 | $195 | $12 |
| Amlodipine Besylate | 13 | $192 | $15 |
| Hydrocodone-Acetaminophen | 12 | $186 | $15 |
| Atenolol | 21 | $177 | $8 |
| Naproxen | 11 | $166 | $15 |
| Lisinopril-Hydrochlorothiazide | 13 | $149 | $11 |
| Azithromycin | 17 | $146 | $9 |
| Hydrochlorothiazide | 33 | $123 | $4 |
| Paroxetine | 13 | $107 | $8 |
| Lisinopril | 12 | $103 | $9 |
| Diazepam | 12 | $39 | $3 |
2013: 11 drugs
| Losartan | 41 | $822 | $20 |
| Bupropion Xl | 15 | $673 | $45 |
| Fluoxetine | 14 | $670 | $48 |
| Simvastatin | 49 | $628 | $13 |
| Omeprazole | 17 | $521 | $31 |
| Levothyroxine | 28 | $451 | $16 |
| Metformin | 31 | $349 | $11 |
| Sertraline | 14 | $203 | $15 |
| Azithromycin | 12 | $144 | $12 |
| Atenolol | 21 | $140 | $7 |
| Hydrochlorothiazide | 19 | $52 | $3 |
Money from drug and device companies
$329 in 2025
| 2025 | 7 | 10 | None | $329 |
| 2024 | 5 | 23 | None | $425 |
| 2023 | 6 | 8 | None | $183 |
| 2022 | 3 | 4 | None | $94 |
| 2021 | 3 | 6 | None | $216 |
| 2020 | 5 | 6 | None | $113 |
| 2019 | 15 | 27 | None | $628 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $125 | 1 payment
|
| Abbvie | Qulipta | $66 | 3 payments
|
| Pfizer | Prevnar 20 | $44 | 2 payments
|
| Lilly USA | Kisunla | $27 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $25 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $23 | 1 payment
|
See all 10 published payments
| Pfizer | Meals · 2025-11-13 | Prevnar 20 | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-10 | None | $18 |
| Abbvie | Meals · 2025-11-03 | Ubrelvy | $19 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-29 | Caplyta | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-08 | Kerendia | $23 |
| Pfizer | Meals · 2025-07-28 | Prevnar 20 | $24 |
| Lilly USA | Meals · 2025-07-17 | Kisunla | $27 |
| Abbvie | Meals · 2025-03-29 | Qulipta | $32 |
| Abbvie | Meals · 2025-02-06 | Qulipta | $15 |
| Astellas Pharma US | Meals · 2025-01-30 | Veozah | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $425
| Abbvie | Qulipta | $332 | 18 payments
|
| Pfizer | Prevnar 20 | $38 | 2 payments
|
| Astellas Pharma US | Veozah | $22 | 1 payment
|
| Lilly USA | Mounjaro | $17 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $16 | 1 payment
|
2023: $183
| AbbVie | Qulipta | $60 | 2 payments
|
| Pfizer | Comirnaty | $39 | 2 payments
|
| GlaxoSmithKline | Arexvy | $25 | 1 payment
|
| Hikma Pharmaceuticals USA | Ryaltris | $23 | 1 payment
|
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $20 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $18 | 1 payment
|
2022: $94
| GlaxoSmithKline | Trelegy Ellipta | $53 | 2 payments
|
| Abbvie | Ubrelvy | $25 | 1 payment
|
| Pfizer | Prevnar 20 | $16 | 1 payment
|
2021: $216
| Biohaven Pharmaceuticals | Nurtec Odt | $120 | 1 payment
|
| Pfizer | Premarin | $82 | 4 payments
|
| Novo Nordisk | Rybelsus | $14 | 1 payment
|
2020: $113
| Pfizer | Eucrisa | $39 | 2 payments
|
| Allergan | Ubrelvy | $22 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $21 | 1 payment
|
| Gilead Sciences | Descovy | $18 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $12 | 1 payment
|
2019: $628
| Bausch & Lomb a division of Bausch Health US | Envista Toric | $125 | 1 payment
|
| TherapeuticsMD | Imvexxy | $71 | 4 payments
|
| Teva Pharmaceuticals USA | Ajovy | $56 | 2 payments
|
| Lilly USA | Emgality | $55 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $45 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $44 | 2 payments
|
| GlaxoSmithKline | Shingrix | $39 | 2 payments
|
| Pfizer | Eucrisa | $37 | 2 payments
|
| AMAG Pharmaceuticals | Intrarosa | $34 | 2 payments
|
| Merck Sharp & Dohme | Pneumovax 23 | $29 | 2 payments
|
| Arbor Pharmaceuticals | Horizant | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
| Sanofi Pasteur | Adacel | $14 | 1 payment
|
| Allergan | Namzaric | $13 | 1 payment
|
Professional record
- NPI
- 1568508877
- Licence
- CA 98540California A98540: Current · expires 2029-01-31
- Trained
- University of California, San Diego School of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 360 Dardanelli Ln, Suite 2e, Los Gatos, CA, 95032
- NPI first listed
- 2007-01-30
- NPI last updated
- 2022-12-07
- NPI record certified
- 2022-12-07
This is when the NPI record was last certified, not a medical board exam.